Aosen (Hong Kong) Pharmacia Limited was established in 2013 and is a company that integrates research, development, production, and sales. It is deeply rooted in advanced fields such as the big health industry, beauty industry, and pharmaceuticals under the call of national health policies.

Aosen Hong Kong's strategic partner in China, China Medical and Health Products Import and Export Co., Ltd., is the only importer of Orson Hong Kong in China.

The production base of Dr. oberstan, a subsidiary of Dr. Oberstan, in Hong Kong is Kodak Pharmaceuticals. Dr. Oberstan has two major research centers worldwide: Switzerland and Greece; Four major production bases: Hong Kong, Greece, Cambodia, and Spain.

Aosen Health is divided into four major departments: the Great Health Food Business Unit, the Pharmaceutical Business Unit, the Medical Device Business Unit, and the Beauty Business Unit, including imported health products, imported green food, imported medical beauty products, imported cosmetics, imported mother and baby food, and imported mother and baby supplies.